TW202400144A - 登革熱病毒感染之治療及/或預防 - Google Patents
登革熱病毒感染之治療及/或預防 Download PDFInfo
- Publication number
- TW202400144A TW202400144A TW112116717A TW112116717A TW202400144A TW 202400144 A TW202400144 A TW 202400144A TW 112116717 A TW112116717 A TW 112116717A TW 112116717 A TW112116717 A TW 112116717A TW 202400144 A TW202400144 A TW 202400144A
- Authority
- TW
- Taiwan
- Prior art keywords
- days
- compound
- kcal
- fat
- day
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263341074P | 2022-05-12 | 2022-05-12 | |
| US63/341,074 | 2022-05-12 | ||
| WOPCT/IB2023/054527 | 2023-05-01 | ||
| PCT/IB2023/054527 WO2023218285A1 (en) | 2022-05-12 | 2023-05-01 | Treatment or prevention of dengue viral infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202400144A true TW202400144A (zh) | 2024-01-01 |
Family
ID=86558745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW112116717A TW202400144A (zh) | 2022-05-12 | 2023-05-05 | 登革熱病毒感染之治療及/或預防 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250281457A1 (enExample) |
| EP (1) | EP4522163A1 (enExample) |
| JP (1) | JP2025517683A (enExample) |
| CN (1) | CN119173261A (enExample) |
| AU (1) | AU2023269343A1 (enExample) |
| CA (1) | CA3257185A1 (enExample) |
| TW (1) | TW202400144A (enExample) |
| WO (1) | WO2023218285A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025253267A1 (en) | 2024-06-06 | 2025-12-11 | Janssen Pharmaceuticals, Inc. | Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20160086B1 (ar) | 2015-05-08 | 2021-08-17 | 2 Katholieke Univ Leuven Ku Leuven Research And Development | مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك |
| CN114980884A (zh) * | 2019-11-15 | 2022-08-30 | 杨森制药公司 | 登革热疾病的治疗和预防 |
-
2023
- 2023-05-01 AU AU2023269343A patent/AU2023269343A1/en active Pending
- 2023-05-01 CN CN202380039672.0A patent/CN119173261A/zh active Pending
- 2023-05-01 EP EP23726180.5A patent/EP4522163A1/en active Pending
- 2023-05-01 CA CA3257185A patent/CA3257185A1/en active Pending
- 2023-05-01 WO PCT/IB2023/054527 patent/WO2023218285A1/en not_active Ceased
- 2023-05-01 JP JP2024566556A patent/JP2025517683A/ja active Pending
- 2023-05-01 US US18/862,833 patent/US20250281457A1/en active Pending
- 2023-05-05 TW TW112116717A patent/TW202400144A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2025517683A (ja) | 2025-06-10 |
| CA3257185A1 (en) | 2023-11-16 |
| US20250281457A1 (en) | 2025-09-11 |
| AU2023269343A1 (en) | 2025-01-02 |
| CN119173261A (zh) | 2024-12-20 |
| EP4522163A1 (en) | 2025-03-19 |
| WO2023218285A1 (en) | 2023-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102121329B1 (ko) | 테노포비르 및 엠트리시타빈을 포함하는 제약 제제 | |
| JP2931409B2 (ja) | パラセタモール及びドンペリドンのフィルムコーティング錠 | |
| US20030147950A1 (en) | Modified release tamsulosin tablets | |
| KR100651110B1 (ko) | 테르비나핀을 포함하는 제약학적 조성물 및 그의 용도 | |
| CN111278433A (zh) | 尼拉帕尼制剂 | |
| TW201238612A (en) | Therapeutic compositions | |
| US20150150867A1 (en) | Compositions of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine | |
| KR20200037880A (ko) | 제약 제제 | |
| US20170014340A1 (en) | Orally Disintegrating Tablet of Nabilone Comprising Mannitol-Based Granules | |
| AU2012357956A1 (en) | Immediate release multi unit pellet system | |
| EP4240331B1 (en) | Solid formulation | |
| US20250281457A1 (en) | Treatment or prevention of dengue viral infection | |
| TW201834643A (zh) | 包含鹽酸依托必利之速釋和緩釋藥物製劑 | |
| US20210369624A1 (en) | Solid oral dosage form having excellent dissolution properties | |
| CN113164436A (zh) | 药物组合物 | |
| JP2023071921A (ja) | 様々な用量のレナリドミドの経口用錠剤組成物 | |
| HK40120143A (zh) | 登革热病毒感染的治疗和/或预防 | |
| TWI923631B (zh) | 固體配製物 | |
| US20110262540A1 (en) | Solid Pharmaceutical Composition Comprising Exemestane | |
| JPWO2003075919A1 (ja) | 塩酸ピルジカイニド含有錠剤(乾式) | |
| JP4866170B2 (ja) | 睡眠薬の放出制御医薬組成物及びその製造方法 | |
| WO2012148225A2 (en) | Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same | |
| US20250367137A1 (en) | Phloroglucinol Formulations And Methods Of Use | |
| HK40099185A (zh) | 固体制剂 | |
| EP4647130A2 (en) | Pharmaceutical composition comprising eliglustat |